Researchers urge European policymakers to make adequate resources available to tackle pancreatic cancer
Researchers have called on European policymakers to make adequate resources available to tackle pancreatic cancer, a disease that is almost invariably fatal and where little progress has been made over the past 40 years.
In the latest predictions for cancer deaths in the EU and UK for 2021, published in the leading cancer journal
Annals of Oncology today (Monday), researchers led by Carlo La Vecchia (MD), a professor at the University of Milan (Italy), say that pancreatic death rates are predicted to remain approximately stable for men, but continue to rise in women in most EU countries.
This is the third approval for Libtayo, following approvals as the first immunotherapy for patients with advanced basal cell carcinoma and as the first systemic treatment for advanced cutaneous squamous cell carcinoma.<br />
Kelly got the phone call, and a series of events that confirmed her doctor’s hunch - cervical cancer which lead to a radical hysterectomy and by all indications at the time, a good prognosis.
The compilation also featured pictures and videos of past THON children and their families.
The hour featured dozens of mini stories from THON children and their families, interspersed with three longer, personal family stories.
The first two stories â those of the Hailey Dougherty family and the Makenna Linder â spoke of current treatments and survival. The final story â that of Nickolas Akright â spoke of Akrightâs death by suicide following treatment.
Each family discussed what motivates them to keep fighting, and the help that Four Diamonds and THON have given them along the way.
Here are their stories.Â
By Jeremiah Hassel
Study reveals extremely low detection of SARS-CoV-2 on surfaces in oncology facilities
Researchers from Rutgers Cancer Institute of New Jersey, the state s only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility.
The study revealed extremely low detection of SARS-CoV-2 on environmental surfaces across multiple outpatient and inpatient oncology areas, including an active COVID-19 floor. Andrew M. Evens, DO, MSc, FACP, associate director for clinical services and director of the Lymphoma Program at Rutgers Cancer Institute and medical director of the oncology service line at RWJBarnabas Health, is senior author of the work, which has been published in the February 18 online edition of